Table 4 Relation between BNP (before and after treatment) level and different parameters
BNP level | |||||
|---|---|---|---|---|---|
N | Before | After | |||
Median(min.–max.) | Mean ± SD. | Median(min.–max.) | Mean ± SD. | ||
Sex | |||||
Male | 26 | 14.8(6.1–34) | 18.2 ± 7.5 | 16.5(22.3 ± 12) | 22.3 ± 12 |
Female | 63 | 16.2(0.7–165.5) | 22.8 ± 28 | 18.5(8.7–180.7) | 25.2 ± 29.5 |
U(p) | 812.0(0.950) | 742.0(0.487) | |||
BMI | |||||
18.5–24.9 | 22 | 15.8(6.1–84.8) | 20.3 ± 15.4 | 16.9(13.4–23.9 | 17.1 ± 3.1 |
25.0–29.9 | 67 | 16.2(0.7–165.5) | 21.8 ± 26.2 | 18.6(8.7–180.7) | 26.2 ± 28.4 |
U(p) | 716.50(0.845) | 464.50(0.075) | |||
Type drug | |||||
SOF + AC | 63 | 15.8(0.7–64.8) | 18.8 ± 10.6 | 18.6(10.8–180.7) | 26.2 ± 27.9 |
SOF + DAC + RIB | 26 | 16.9(6.1–165.5) | 27.7 ± 40.9 | 16.7(8.7–43.4) | 20 ± 9.7 |
U(p) | 782.0(0.738) | 668.0(0.173) | |||
FIB4 | |||||
< 1.45 | 43 | 14.2(0.7–22.9) | 13.7 ± 4.4 | 18.8(10.8–180.7) | 28.9 ± 32.9 |
1.45–3.25 | 42 | 19.2(12.5–64.8) | 22.7 ± 11.3 | 17.5(8.7–34.5) | 18.4 ± 6 |
> 3.25 | 4 | 91.2(16.9–165.5) | 91.2 ± 85.8 | – | – |
H(p) | 27.925*(<0.001*) | 760.0(0.083) | |||
APRI | |||||
< 0.5 | 46 | 14.8(0.7–241) | 14.5 ± 5.1 | 18.8(8.7–180.7) | 27.5 ± 32.5 |
0.5–1.5 | 39 | 17.6(12.8–34) | 19.9 ± 6.3 | 17.1(10.8–43.4) | 20.1 ± 8.8 |
> 1.5 | 4 | 115.1(64.8–165.5) | 115.1 ± 58.2 | – | – |
H(p) | 24.899*(<0.001*) | 807.0(0.197) | |||
Liver echogenicity | |||||
Cirrhosis | 28 | 23.5(6.1–165.5) | 31.9 ± 38.4 | 17.2(8.7–34.5) | 19.1 ± 6.5 |
Normal | 61 | 14.8(0.7–64.8) | 16.6 ± 9.9 | 18.6(10.8–180.7) | 26.8 ± 30.4 |
U(p) | 336.0(<0.001*) | 746.0(0.340) | |||